Class I glucose transporters as therapeutic targets in ADVd, androgen-independent prostate cancer
Abstract
The research goal is to inhibit glucose metabolism to significantly reduce prostate cancer growth in the lab and animal models.
Keywords:
translational biomedical sciences, prostate cancer, metabolism, small compound
Status
G
Department
Biomedical Sciences
College
Heritage College of Osteopathic Medicine
Campus
Athens
Faculty Mentor
Rosol, Thomas
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
COinS
Class I glucose transporters as therapeutic targets in ADVd, androgen-independent prostate cancer
The research goal is to inhibit glucose metabolism to significantly reduce prostate cancer growth in the lab and animal models.
Social Media Link
Facebook: Nathan Hoggard